Cargando…

Production of Antihypertensive Angiotensin I-Converting Enzyme Inhibitor from Malassezia pachydermatis G-14

To produce a novel antihypertensive angiotensin I-converting enzyme (ACE) inhibitor from yeast, a yeast isolate, designated G-14 showing the highest ACE inhibitory activity was obtained and identified as Malassezia pachydermatis based on morphological, biochemical and cultural characteristics. The m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Seung Chan, Kim, Jae Ho, Kim, Na-Mi, Lee, Jong Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Mycology 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774874/ https://www.ncbi.nlm.nih.gov/pubmed/24049490 http://dx.doi.org/10.4489/MYCO.2005.33.3.142

Ejemplares similares

Malassezia pachydermatis Carriage in Dog Owners
por: Morris, Daniel O., et al.
Publicado: (2005)

Malassezia pachydermatis keratomycosis in a dog
por: Ledbetter, Eric C., et al.
Publicado: (2016)

First Case of Catheter-related Malassezia pachydermatis Fungemia in an Adult
por: Lee, Jaehyeon, et al.
Publicado: (2019)

Malassezia pachydermatis fungemia in an adult with multibacillary leprosy
por: Roman, Jorge, et al.
Publicado: (2016)

Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis
por: Peano, Andrea, et al.
Publicado: (2017)

Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan
por: MURAYAMA, Nobuo, et al.
Publicado: (2023)

Genotyping and characterisation of the secretory lipolytic enzymes of Malassezia pachydermatis isolates collected from dogs
por: Teramoto, Hideshi, et al.
Publicado: (2015)

Antifungal Resistance Regarding Malassezia pachydermatis: Where Are We Now?
por: Peano, Andrea, et al.
Publicado: (2020)

New Therapeutic Candidates for the Treatment of Malassezia pachydermatis -Associated Infections
por: Sastoque, Angie, et al.
Publicado: (2020)

ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis
por: Díaz, Leyna, et al.
Publicado: (2022)

Malassezia pachydermatis fungemia in a preterm neonate resistant to fluconazole and flucytosine
por: Al-Sweih, Noura, et al.
Publicado: (2014)

CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole
por: Nascente, Patrícia da Silva, et al.
Publicado: (2009)

Susceptibility variation of Malassezia pachydermatis to antifungal agents according to isolate source
por: Weiler, Caroline Borges, et al.
Publicado: (2013)

Azole resistance of Malassezia pachydermatis causing treatment failure in a dog
por: Angileri, Martina, et al.
Publicado: (2018)

In vitro effects of omeprazole in combination with antifungal compounds against Malassezia pachydermatis
por: Shin, Juyoung, et al.
Publicado: (2023)

Efficacy of Amitraz plus Metaflumizone for the treatment of canine demodicosis associated with Malassezia pachydermatis
por: Tarallo, Viviana D, et al.
Publicado: (2009)

In Vitro Biofilm Formation by Malassezia pachydermatis Isolates and Its Susceptibility to Azole Antifungals
por: Čonková, Eva, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Draft Genome Sequence of the Animal and Human Pathogen Malassezia pachydermatis Strain CBS 1879
por: Triana, Sergio, et al.
Publicado: (2015)

A Ketoconazole Susceptibility Test for Malassezia pachydermatis Using Modified Leeming–Notman Agar
por: Hsieh, Bo-Young, et al.
Publicado: (2018)

Invasive Malassezia pachydermatis Infection in an 8-Year-Old Child on Lipid Parenteral Nutrition
por: Teoh, Zheyi, et al.
Publicado: (2022)

Characterization of an Antihypertensive Angiotensin I-Converting Enzyme Inhibitory Peptide from the Edible Mushroom Hypsizygus marmoreus
por: Kang, Min-Gu, et al.
Publicado: (2013)

Marketing research on the angiotensin-converting enzyme inhibitors antihypertensive medicines
por: BOBOIA, ANAMARIA, et al.
Publicado: (2017)

Galleria mellonella as a Novelty in vivo Model of Host-Pathogen Interaction for Malassezia furfur CBS 1878 and Malassezia pachydermatis CBS 1879
por: Torres, Maritza, et al.
Publicado: (2020)

In Vitro Activity of Farnesol against Malassezia pachydermatis Isolates from Otitis Externa Cases in Dogs
por: Olabode, Ifarajimi Rapheal, et al.
Publicado: (2023)

In vitro antifungal activity of cold atmospheric microwave plasma and synergistic activity against Malassezia pachydermatis when combined with chlorhexidine gluconate
por: Lee, Tae‐Hyun, et al.
Publicado: (2022)

Production of Antihypertensive Angiotensin I-Converting Enzyme Inhibitor-Enriched Edible Yeast Using Gugija (Lycium chinesis Mill)
por: Kim, Ran, et al.
Publicado: (2010)

Digestion Pattern of Antihypertensive Angiotensin I-Converting Enzyme Inhibitory Peptides from Saccharomyces cerevisiae in a Successive Simulated Gastricintestinal Bioreactor
por: Jang, Jeong-Hoon, et al.
Publicado: (2011)

A Cluster of Fluconazole-Resistant Malassezia pachydermatis in a Neonatal Intensive Care Unit — California, 2015–2016
por: Chinn, Raymond, et al.
Publicado: (2017)

Susceptibility of Malassezia pachydermatis Clinical Isolates to Allopathic Antifungals and Brazilian Red, Green, and Brown Propolis Extracts
por: Deegan, Kathleen Ramos, et al.
Publicado: (2019)

Antifungal susceptibility of Malassezia pachydermatis isolated from the external auditive conduct from dogs, in central Chile
por: Núñez, Andrea H., et al.
Publicado: (2022)

In Vitro Susceptibility of Malassezia pachydermatis Isolates from Canine Skin with Atopic Dermatitis to Ketoconazole and Itraconazole in East Asia
por: WATANABE, Shion, et al.
Publicado: (2013)

Characterization of the species Malassezia pachydermatis and re-evaluation of its lipid dependence using a synthetic agar medium
por: Puig, Laura, et al.
Publicado: (2017)

Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
por: Bönner, G, et al.
Publicado: (2013)

Antihypertensive Effects of Artemisia scoparia Waldst in Spontaneously Hypertensive Rats and Identification of Angiotensin I Converting Enzyme Inhibitors
por: Cho, Jeong-Yong, et al.
Publicado: (2015)

Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection
por: Bellavita, Rosa, et al.
Publicado: (2020)

Whole-Genome Sequencing and De Novo Assembly of Malassezia pachydermatis Isolated from the Ear Canal of a Dog with Otitis
por: D’Andreano, S., et al.
Publicado: (2021)

STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS
por: Manoharan, Sivananthan, et al.
Publicado: (2017)

Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs—Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Bryniarski, Paweł, et al.
Publicado: (2022)

Antihypertensive Angiotensin I-Converting Enzyme Inhibitory Activity and Antioxidant Activity of Vitis hybrid-Vitis coignetiae Red Wine Made with Saccharomyces cerevisiae
por: Jang, Jeong-Hoon, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cb67ci7tls71vmjv66qlfafetl